0
2022
Albumin Market

Albumin Market

by Type (Human Serum Albumin, Bovine Serum, and, Recombinant Albumin) and Application (Therapeutics, Drug Formulation & Vaccines, Component of Media, and Others): Global Opportunity Analysis and Industry Forecast, 2021--2030

✷  Report Code: A02251
Pages: 200
Feb 2022 | 17384 Views
Author(s) : Divyani T, Swapna S
Tables: 90
Charts: 41
  • Formats*:

  • Single User License, Five User
    License & Enterprise User License

  • Data Pack Excel License

  • It comes with the additional cost
    of $2500.00 contact sales.

 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Albumin Market

Request Now !

Albumin Market Overview

The Albumin market was valued at $4,813.5 million in 2020, and is estimated to reach $8,956.07 million by 2030, growing at a CAGR of 6.4% from 2021 to 2030.

Albumin is the most abundant protein, which is found in blood plasma. Therapeutically, it is used to replace lost fluids and helps to restore blood volume following trauma, burns, surgeries, infections, and liver diseases. It assists in the stabilization of drugs by reducing aggregation, oxidation, and surface absorption. Different types of serum albumin are widely used for clinical applications. Human serum albumin and bovine serum albumin are obtained from human plasma and bovine plasma, respectively.

Market Infographics _Global Albumin Market

Growth of the global albumin market is majorly driven by increase in prevalence of life-threatening disorders, special liver diseases, infections, and cardiac surgeries leading to hypoalbuminemia as well as development of new albumin products by large number of key players. Factors that fuel the growth of the albumin market are increase in demand for albumin in R&D activities, rise in non-therapeutic application of albumin, development of plant-based albumin, rise in production of immunoglobulins & plasma collection . According to the World Health Organization approximately 235 million major surgical procedures were performed in 2019 across the globe. According to the National Cancer Statistics in 2020, around 1,806,590 new cases of cancer were reported in the U.S. Therefore, the growth in number of cancer surgeries can lead to cause hypoalbuminemia, which is anticipated to boost the growth of the market.

In addition, increase in use of albumin injection for cardiopulmonary bypass surgery, and surge in use to treat hypoalbuminemia in patients with severe injuries, and pancreatitis are the factors that enhance the growth of the market.  Furthermore, increase in number of product approvals are expected to provide remunerative opportunities for the expansion of the global albumin market during the forecast period.

COVID-19 Scenario Analysis

The COVID-19 outbreak is anticipated to have a positive impact to fuel the growth of the global albumin market. Rise in use of albumin for the production of vaccines such as Covishield and Covaxin for the treatment of COVID-19 infection results in increase in the usage of albumin. For instance, according to the National Clinical Trial Registry, there are about 10 planned and ongoing trials related to albumin for the development of vaccines for COVID-19 virus.  Thus, rise in production of vaccines has increased the usage of albumin, which is anticipated to drive the albumin market during the forecast period.

Thus, new innovations by key players and rise in number of product approvals propel the growth of the market. However, stringent government regulations associated with the adoption of albumin products are expected to restrict the market growth during the forecast period.

Albumin Market Segmentation

The albumin market is segmented on the basis of type, application, end user, and region. By type, the market is categorized into human serum albumin, bovine serum albumin, and recombinant albumin. On the basis of application, it is divided into therapeutics, drug formulation & vaccines, component of media, and other. Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).

Albumin Market
By Type

Your browser does not support the canvas element.

Human Serum Albumin segment holds a dominant position in 2020 and would continue to maintain the lead over the forecast period.

Get more information on this report : Request Sample Pages

Segment Review

By type, the human serum albumin segment dominated the market in 2020, and this trend is expected to continue during the forecast period, owing to increase in R&D activities in the pharmaceutical industry, rise in demand for drug development, and surge in adoption of albumin products. However, the recombinant albumin segment is expected to witness considerable growth during the forecast period, owing to increase in number of surgeries due to hypoalbuminemia and rise in number of key players for development of albumin.

By application, the therapeutics segment was the major contributor in 2020, and is expected to maintain its lead during the forecast period, owing to increase in prevalence of burns and trauma cases, rise in number of cardiac disorders, and increase in demand for albumin in drug discovery. However, the drug formulations and vaccines is expected to witness considerable growth during the forecast period, due to increase in number of cancer cases.

Albumin Market
By Application

Your browser does not support the canvas element.

Therapeutics segment is projected as one of the most lucrative segment.

Get more information on this report : Request Sample Pages

North America garnered the major share in the albumin market in 2020, and is expected to continue to dominate during the forecast period, owing to rise in number of life-threatening disorders such as liver and kidney diseases, presence of key players, development of the healthcare sector, and presence of new albumin products in the region. However, Asia-Pacific is expected to register the highest CAGR of 7.7% from 2021 to 2030, owing to increase in prevalence of chronic diseases led to increase number of surgeries results in cause of hypoalbumenia and development of healthcare infrastructure.

The key players that operate in the global albumin market include Baxter International Inc., China Biologic Products, Inc, CSL Limited, Grifols, S.A., Merck KGaA, Novozymes, Octapharma AG, Takeda Pharmaceuticals Inc, Thermo Fisher Scientific, and Ventria Bioscience.

Albumin Market
By Region

2030
North America 
Europe
Asia-Pacific
LAMEA

Asia-Pacific is expected to experience growth at the highest rate, registering a CAGR of 7.7% during the forecast period.

Get more information on this report : Request Sample Pages

Key Benefits for Stakeholders

  • The study provides an in-depth analysis of the albumin market, and the current trends & future estimations to elucidate imminent investment pockets.
  • It presents a quantitative analysis of the market from 2021 to 2030 to enable stakeholders to capitalize on the prevailing market opportunities.
  • Extensive analysis of the market based on procedures and services assists to understand the trends in the industry.
  • Key players and their strategies are thoroughly analyzed to understand the competitive outlook of the market.

Albumin Market Report Highlights

Aspects Details
By Type
  • Human Serum Albumin
  • Bovine Serum Albumin
  • Recombinant Albumin
By Application
  • Therapeutics
  • Drug Formulation & Vaccines
  • Component of Media
  • Other
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (Germany, France, UK, Italy, Spain, Rest of Europe)
  • Asia-Pacific  (Japan, China, Australia, India, South Korea, Rest of Asia-Pacific)
  • LAMEA  (Brazil, Saudi Arabia, South Africa, Rest of LAMEA)
By Key Market Players
  • Baxter International Inc.
  • China Biologic Products, Inc.
  • CSL Limited
  • Grifols, S.A
  • Merck KGaA
  • Novozymes
  • Octapharma AG
  • Takeda Pharmaceuticals Inc,
  • Thermo Fisher Scientific
  • Ventria Bioscience
 

Loading Table Of Content...


 
 

This section provides the opinions of the CXOs of key companies operating in the albumin industry. Serum albumin is the most abundant plasma protein, constituting approximately 50% of the total human plasma protein. It is produced in the liver that maintains oncotic blood pressure, and transports hormones, fatty acids, and other compounds. It is obtained by fractionation from the human and animal plasma and is further used to treat different disorders.

As per the CXOs, rise in patients suffering from life-threatening diseases and conditions, especially hypoalbuminemia, is the major factor that drives the growth of the global albumin market. Other factors such as increase in demand for albumin products, rise in non-therapeutic application of albumin, and surge in preference for the use of recombinant albumin products in various treatments are expected to have a significant impact on the growth of the market. However, factors such as stringent governmental regulations and post-operative risks associated with the donated albumin hamper the market growth.

The use of albumin is the highest in North America, owing to a large patient population and high adoption of recombinant albumin, and is followed by Europe and Asia-Pacific. In addition, albumin providers and distributors focus on expanding their presence in the emerging economies, which, in turn, is anticipated to drive the market growth.

 

 

PURCHASE OPTIONS

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : + 44-845-528-1300
Email : help@alliedmarketresearch.com
 
FREQUENTLY ASKED QUESTIONS?

A. The total market value of Albumin market is $ 4,813.5 million in 2020.

A. The forecast period for Albumin market is 2021 to 2030

A. The market value of Albumin market in 2021 is $ 5,131.19 million.

A. The base year is 2020 in Albumin market

A. Top companies such as Baxter International Inc, China Biologic Products, Inc, CSL Limited , Grifols, S.A, Merck KGaA, Novozymes, Octapharma AG, Takeda Pharmaceuticals Inc, Thermo Fisher Scientific, Ventria Bioscience held a high market position in 2020.

A. Human Serum Albumin segment dominated the global market in 2020, and expected to continue this trend throughout the forecast period due to the technological advancements and new product launch and thus is expected to drive the segment

A. Increase in prevalence of trauma, burns patients, advanced infrastructure for research & development and investments in healthcare is anticipated to drive the market in the forecast period.

A. North America is projected to account for a major share of the global albumin market during the forecast period. U.S. dominated the North America rise in investments for new albumin system launch in the R & D sector due to presence of key players across the country.

A. Albumin is globular protein found in blood plasma

A. Albumin are used treatment of various diseases including surgical blood loss, shock, burns, trauma, chronic liver disease, hypovolemia, hemorrhage, acute liver failure

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Request Free Sample
RELATED TAGS

Purchase Full Report of
Albumin Market

Start reading instantly.
This Report and over 19,654+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,712
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
    (Feb 2023 - Feb 2024)
  • Data Pack
  • $4,125
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Feb 2023 - Feb 2024)
  • Single User
  • $5,769
  • Restricted to one authorized user
  • One print only
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Feb 2023 - Feb 2024)
  • Five Users
  • $6,929
  • Limited to five authorized users
  • Print upto five copies
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Feb 2023 - Feb 2024)
  • Enterprise
    License/PDF

  • $10,663
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Feb 2023 - Feb 2024)
  • Library
    Membership

  • $ 1,175
    Per User/ Per month/ Billed annually
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

RELATED REPORTS
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers